Farez et al. demonstrated that melatonin contributes to the amelioration of autoimmune diseases, such as multiple sclerosis, by both suppressing the differentiation of pathogenic Th17 cells via RORγ, and promoting the development of protective Tr1 via RORα [61]. Here, RORC is linked to multiple sclerosis.